High-resolution imaging with high and ultra high-field magnetic resonance imaging systems

Tsutomu Nakada, Hitoshi Matsuzawa, Ingrid Kwee

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The development of noninvasive methods capable of affording ever higher resolution images is an ongoing major objective of scientific investigation for the benefit of both clinical medicine and neuroscience. Since its development in the early 1970s, magnetic resonance imaging (MRI) has remained a technology of choice for medical imaging development because of the wide range of potential clinical applications. Although conventional systems with field strengths of 1.0-1.5 T rapidly popularized MRI in general clinical practice in the 1980s, research investigations have focused on imaging yielding much higher anatomical resolution using high (3.0-4.0 T) and ultra high-field (7.0-9.0 T) systems. The substantial clinical experience with high and ultra high-field systems has made evident that there is a definite limit to which higher spatial resolution in and of itself will improve information for clinical judgment, rather, it is essential to develop the entire study as a whole, which would allow for the selection of an optimal combination of all the study elements, especially the appropriate contrast mechanism. This process is analogous to the development of suitable stains for a given pathologic process in histological techniques. In MRI, the natural physico-chemical MR contrast properties of tissues can be taken advantage of to achieve this goal, thereby obviating the need for administering contrast material to individuals.

Original languageEnglish (US)
Pages (from-to)7-13
Number of pages7
JournalNeuroReport
Volume19
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Magnetic Resonance Imaging
Histological Techniques
Clinical Medicine
Pathologic Processes
Diagnostic Imaging
Neurosciences
General Practice
Contrast Media
Coloring Agents
Technology
Research

Keywords

  • Magnetic resonance imaging
  • Magnetic resonance microscopy
  • Senile plaque
  • Susceptibility weighted imaging
  • Three-dimensional anisotropy contrast

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

High-resolution imaging with high and ultra high-field magnetic resonance imaging systems. / Nakada, Tsutomu; Matsuzawa, Hitoshi; Kwee, Ingrid.

In: NeuroReport, Vol. 19, No. 1, 01.2008, p. 7-13.

Research output: Contribution to journalArticle

Nakada, Tsutomu ; Matsuzawa, Hitoshi ; Kwee, Ingrid. / High-resolution imaging with high and ultra high-field magnetic resonance imaging systems. In: NeuroReport. 2008 ; Vol. 19, No. 1. pp. 7-13.
@article{27cf443791a842faa6dc37cbfde83a6d,
title = "High-resolution imaging with high and ultra high-field magnetic resonance imaging systems",
abstract = "The development of noninvasive methods capable of affording ever higher resolution images is an ongoing major objective of scientific investigation for the benefit of both clinical medicine and neuroscience. Since its development in the early 1970s, magnetic resonance imaging (MRI) has remained a technology of choice for medical imaging development because of the wide range of potential clinical applications. Although conventional systems with field strengths of 1.0-1.5 T rapidly popularized MRI in general clinical practice in the 1980s, research investigations have focused on imaging yielding much higher anatomical resolution using high (3.0-4.0 T) and ultra high-field (7.0-9.0 T) systems. The substantial clinical experience with high and ultra high-field systems has made evident that there is a definite limit to which higher spatial resolution in and of itself will improve information for clinical judgment, rather, it is essential to develop the entire study as a whole, which would allow for the selection of an optimal combination of all the study elements, especially the appropriate contrast mechanism. This process is analogous to the development of suitable stains for a given pathologic process in histological techniques. In MRI, the natural physico-chemical MR contrast properties of tissues can be taken advantage of to achieve this goal, thereby obviating the need for administering contrast material to individuals.",
keywords = "Magnetic resonance imaging, Magnetic resonance microscopy, Senile plaque, Susceptibility weighted imaging, Three-dimensional anisotropy contrast",
author = "Tsutomu Nakada and Hitoshi Matsuzawa and Ingrid Kwee",
year = "2008",
month = "1",
doi = "10.1097/WNR.0b013e3282f2e00b",
language = "English (US)",
volume = "19",
pages = "7--13",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - High-resolution imaging with high and ultra high-field magnetic resonance imaging systems

AU - Nakada, Tsutomu

AU - Matsuzawa, Hitoshi

AU - Kwee, Ingrid

PY - 2008/1

Y1 - 2008/1

N2 - The development of noninvasive methods capable of affording ever higher resolution images is an ongoing major objective of scientific investigation for the benefit of both clinical medicine and neuroscience. Since its development in the early 1970s, magnetic resonance imaging (MRI) has remained a technology of choice for medical imaging development because of the wide range of potential clinical applications. Although conventional systems with field strengths of 1.0-1.5 T rapidly popularized MRI in general clinical practice in the 1980s, research investigations have focused on imaging yielding much higher anatomical resolution using high (3.0-4.0 T) and ultra high-field (7.0-9.0 T) systems. The substantial clinical experience with high and ultra high-field systems has made evident that there is a definite limit to which higher spatial resolution in and of itself will improve information for clinical judgment, rather, it is essential to develop the entire study as a whole, which would allow for the selection of an optimal combination of all the study elements, especially the appropriate contrast mechanism. This process is analogous to the development of suitable stains for a given pathologic process in histological techniques. In MRI, the natural physico-chemical MR contrast properties of tissues can be taken advantage of to achieve this goal, thereby obviating the need for administering contrast material to individuals.

AB - The development of noninvasive methods capable of affording ever higher resolution images is an ongoing major objective of scientific investigation for the benefit of both clinical medicine and neuroscience. Since its development in the early 1970s, magnetic resonance imaging (MRI) has remained a technology of choice for medical imaging development because of the wide range of potential clinical applications. Although conventional systems with field strengths of 1.0-1.5 T rapidly popularized MRI in general clinical practice in the 1980s, research investigations have focused on imaging yielding much higher anatomical resolution using high (3.0-4.0 T) and ultra high-field (7.0-9.0 T) systems. The substantial clinical experience with high and ultra high-field systems has made evident that there is a definite limit to which higher spatial resolution in and of itself will improve information for clinical judgment, rather, it is essential to develop the entire study as a whole, which would allow for the selection of an optimal combination of all the study elements, especially the appropriate contrast mechanism. This process is analogous to the development of suitable stains for a given pathologic process in histological techniques. In MRI, the natural physico-chemical MR contrast properties of tissues can be taken advantage of to achieve this goal, thereby obviating the need for administering contrast material to individuals.

KW - Magnetic resonance imaging

KW - Magnetic resonance microscopy

KW - Senile plaque

KW - Susceptibility weighted imaging

KW - Three-dimensional anisotropy contrast

UR - http://www.scopus.com/inward/record.url?scp=40349087301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40349087301&partnerID=8YFLogxK

U2 - 10.1097/WNR.0b013e3282f2e00b

DO - 10.1097/WNR.0b013e3282f2e00b

M3 - Article

C2 - 18281884

AN - SCOPUS:40349087301

VL - 19

SP - 7

EP - 13

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 1

ER -